Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial

Robert B. M. Landewe; Jos G. A. Houbiers; Filip van de Bosch; Joanna in't Hout; Patrick C. P. M. Verschueren; Jan H. Meijerink; Frank H. J. van den Hoogen; Bedrich A. Masek; George A. W. Bruyn; Jacques M. G. W. Wouters; Alexandre E. Voskuyl; Jacob M. van Laar; Johannes W J Bijlsma; Desiree M. F. M. van der Heijde; Ferdinand C. Breedveld; Leo B. A. van de Putte; Andre M. M. Miltenburg; Filip De Keyser

doi:10.1136/ard.2009.117234

Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial

Robert B. M. Landewe, Jos G. A. Houbiers, Filip van de Bosch, Joanna in't Hout, Patrick C. P. M. Verschueren, Jan H. Meijerink, Frank H. J. van den Hoogen, Bedrich A. Masek, George A. W. Bruyn, Jacques M. G. W. Wouters, Alexandre E. Voskuyl, Jacob M. van Laar, Johannes W J Bijlsma, Desiree M. F. M. van der Heijde, Ferdinand C. Breedveld, Leo B. A. van de Putte, Andre M. M. Miltenburg^*, Filip De Keyser

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1655-1659
Journal	Annals of the Rheumatic Diseases
Volume	69
Issue number	9
DOIs	https://doi.org/10.1136/ard.2009.117234
Publication status	Published - Sep 2010

Access to Document

10.1136/ard.2009.117234

Cite this

Landewe, R. B. M., Houbiers, J. G. A., van de Bosch, F., in't Hout, J., Verschueren, P. C. P. M., Meijerink, J. H., van den Hoogen, F. H. J., Masek, B. A., Bruyn, G. A. W., Wouters, J. M. G. W., Voskuyl, A. E., van Laar, J. M., Bijlsma, J. W. J., van der Heijde, D. M. F. M., Breedveld, F. C., van de Putte, L. B. A., Miltenburg, A. M. M., & De Keyser, F. (2010). Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial. Annals of the Rheumatic Diseases, 69(9), 1655-1659. https://doi.org/10.1136/ard.2009.117234

Landewe, Robert B. M. ; Houbiers, Jos G. A. ; van de Bosch, Filip ; in't Hout, Joanna ; Verschueren, Patrick C. P. M. ; Meijerink, Jan H. ; van den Hoogen, Frank H. J. ; Masek, Bedrich A. ; Bruyn, George A. W. ; Wouters, Jacques M. G. W. ; Voskuyl, Alexandre E. ; van Laar, Jacob M. ; Bijlsma, Johannes W J ; van der Heijde, Desiree M. F. M. ; Breedveld, Ferdinand C. ; van de Putte, Leo B. A. ; Miltenburg, Andre M. M. ; De Keyser, Filip. / Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial. In: Annals of the Rheumatic Diseases. 2010 ; Vol. 69, No. 9. pp. 1655-1659.

@article{93d0d80b401743c4a6800722d18f87d0,

title = "Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial",

author = "Landewe, {Robert B. M.} and Houbiers, {Jos G. A.} and {van de Bosch}, Filip and {in't Hout}, Joanna and Verschueren, {Patrick C. P. M.} and Meijerink, {Jan H.} and {van den Hoogen}, {Frank H. J.} and Masek, {Bedrich A.} and Bruyn, {George A. W.} and Wouters, {Jacques M. G. W.} and Voskuyl, {Alexandre E.} and {van Laar}, {Jacob M.} and Bijlsma, {Johannes W J} and {van der Heijde}, {Desiree M. F. M.} and Breedveld, {Ferdinand C.} and {van de Putte}, {Leo B. A.} and Miltenburg, {Andre M. M.} and {De Keyser}, Filip",

year = "2010",

month = sep,

doi = "10.1136/ard.2009.117234",

language = "English",

volume = "69",

pages = "1655--1659",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "9",

}

Landewe, RBM, Houbiers, JGA, van de Bosch, F, in't Hout, J, Verschueren, PCPM, Meijerink, JH, van den Hoogen, FHJ, Masek, BA, Bruyn, GAW, Wouters, JMGW, Voskuyl, AE, van Laar, JM, Bijlsma, JWJ, van der Heijde, DMFM, Breedveld, FC, van de Putte, LBA, Miltenburg, AMM & De Keyser, F 2010, 'Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial', Annals of the Rheumatic Diseases, vol. 69, no. 9, pp. 1655-1659. https://doi.org/10.1136/ard.2009.117234

Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial. / Landewe, Robert B. M.; Houbiers, Jos G. A.; van de Bosch, Filip; in't Hout, Joanna; Verschueren, Patrick C. P. M.; Meijerink, Jan H.; van den Hoogen, Frank H. J.; Masek, Bedrich A.; Bruyn, George A. W.; Wouters, Jacques M. G. W.; Voskuyl, Alexandre E.; van Laar, Jacob M.; Bijlsma, Johannes W J; van der Heijde, Desiree M. F. M.; Breedveld, Ferdinand C.; van de Putte, Leo B. A.; Miltenburg, Andre M. M.; De Keyser, Filip.

In: Annals of the Rheumatic Diseases, Vol. 69, No. 9, 09.2010, p. 1655-1659.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial

AU - Landewe, Robert B. M.

AU - Houbiers, Jos G. A.

AU - van de Bosch, Filip

AU - in't Hout, Joanna

AU - Verschueren, Patrick C. P. M.

AU - Meijerink, Jan H.

AU - van den Hoogen, Frank H. J.

AU - Masek, Bedrich A.

AU - Bruyn, George A. W.

AU - Wouters, Jacques M. G. W.

AU - Voskuyl, Alexandre E.

AU - van Laar, Jacob M.

AU - Bijlsma, Johannes W J

AU - van der Heijde, Desiree M. F. M.

AU - Breedveld, Ferdinand C.

AU - van de Putte, Leo B. A.

AU - Miltenburg, Andre M. M.

AU - De Keyser, Filip

PY - 2010/9

Y1 - 2010/9

U2 - 10.1136/ard.2009.117234

DO - 10.1136/ard.2009.117234

M3 - Article

C2 - 19778914

VL - 69

SP - 1655

EP - 1659

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 9

ER -

Landewe RBM, Houbiers JGA, van de Bosch F, in't Hout J, Verschueren PCPM, Meijerink JH et al. Intranasal administration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: a phase II, multicentre, double-blind, randomised, placebo-controlled, parallel-group, dose-finding trial. Annals of the Rheumatic Diseases. 2010 Sep;69(9):1655-1659. https://doi.org/10.1136/ard.2009.117234